Uniphar PLC on Tuesday announced it expects to meet own expectations for gross profit and earnings before interest, tax, depreciation and amortisation for 2024 following a sound first-half.

Uniphar is a healthcare services business based in Dublin, Ireland. The firm works across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail.

Uniphar reported an estimated 7% increase in gross profit for the six months that ended June 30, performing in line with the firm’s expectations.

Uniphar Pharma delivered strong double-digit organic gross profit growth during the half, and remains on track to achieve double-digit growth for the full year.

Uniphar Medtech achieved low single-digit organic gross profit growth in the period, and is expected to reach high single-digit organic gross profit growth for the full year.

Uniphar Supply Chain & Retail delivered low single-digit organic gross profit growth in the half-year, and is expected to achieve low single-digit organic gross profit growth for the full year.

Looking ahead, the firm said it remains ‘confident’ in delivering current year earnings per share expectations, and enters the second-half of the year with ‘strong trading momentum’.

Chief Executive Officer Ger Rabbette commented: ‘Uniphar has had a great first half, achieving significant organic gross profit growth. We are well-positioned to continue this progress into the second half and meet our growth objectives for each of our three divisions for the full year.’

Uniphar shares were up 2.1% to 210.25 pence per share in London on Tuesday afternoon.

Copyright 2024 Alliance News Ltd. All Rights Reserved.